Streamline Your B Cell Research from Isolation to Expansion
Due to their essential role in the adaptive immune response, B cells continue to be a focal point for infectious disease, cancer, and autoimmune research. Isolating and generating these cells in relevant numbers continues to be a major challenge in the field. Join this on-demand webinar to learn about reagents for efficient B cell isolation and expansion. This workshop features streamlined culture systems that enable feeder- and serum-free expansion of both human and mouse B cells with high yields, thus providing a complete workflow solution for B cell research.
Highly Characterized Human iPSCs and NPCs for Downstream Differentiation Applications
Reproducible research with human induced pluripotent stem cells (iPSCs) depends on access to thoroughly characterized and quality-controlled cell lines. In this webinar, Drs. Andrew Gaffney and Erin Knock will describe the generation of a standardized induced pluripotent stem cell (iPSC) line. Developed with the upcoming ISSCR Standards Initiative characterization guidelines in mind, this highly characterized line is karyotypically stable, demonstrates trilineage differentiation potential, and expresses undifferentiated cell markers. Further, STEMCELL has developed a highly pure, ready-to-use neural progenitor cell product expressing PAX6 and SOX1 over multiple passages. Dr. Knock will show how these multipotent cells are suitable for customized downstream differentiation to various CNS cell types, such as forebrain neurons, midbrain neurons, and astrocytes. These progenitor cells are the ideal controls for standardizing downstream differentiation protocols, modeling diseases, and developing assays.
EasySep™小鼠TIL（CD45）正选试剂盒
Enhancing Genetic Stability in Human Pluripotent Stem Cells Maintained As Single Cells: Introducing eTeSR™ In this Innovation Showcase talk from ISSCR 2023, Dr. Adam Hirst, one of STEMCELL’s Senior Scientists, introduces eTeSR™, a novel hPSC maintenance medium developed specifically to maintain cell quality when passaging hPSCs as single cells.
Streamline Your B Cell Research from Isolation to Expansion Due to their essential role in the adaptive immune response, B cells continue to be a focal point for infectious disease, cancer, and autoimmune research. Isolating and generating these cells in relevant numbers continues to be a major challenge in the field. Join this on-demand webinar to learn about reagents for efficient B cell isolation and expansion. This workshop features streamlined culture systems that enable feeder- and serum-free expansion of both human and mouse B cells with high yields, thus providing a complete workflow solution for B cell research.
Highly Characterized Human iPSCs and NPCs for Downstream Differentiation Applications Reproducible research with human induced pluripotent stem cells (iPSCs) depends on access to thoroughly characterized and quality-controlled cell lines. In this webinar, Drs. Andrew Gaffney and Erin Knock will describe the generation of a standardized induced pluripotent stem cell (iPSC) line. Developed with the upcoming ISSCR Standards Initiative characterization guidelines in mind, this highly characterized line is karyotypically stable, demonstrates trilineage differentiation potential, and expresses undifferentiated cell markers. Further, STEMCELL has developed a highly pure, ready-to-use neural progenitor cell product expressing PAX6 and SOX1 over multiple passages. Dr. Knock will show how these multipotent cells are suitable for customized downstream differentiation to various CNS cell types, such as forebrain neurons, midbrain neurons, and astrocytes. These progenitor cells are the ideal controls for standardizing downstream differentiation protocols, modeling diseases, and developing assays.
